DNOW (DNOW) gains key HSR clearance milestone in merger with MRC Global
Rhea-AI Filing Summary
DNOW Inc. filed an update on its planned merger with MRC Global Inc.. The companies previously agreed that MRC Global will first merge into a DNOW subsidiary and then into another DNOW subsidiary, leaving the combined business as a wholly owned subsidiary of DNOW.
The filing states that a key regulatory milestone has been reached: the statutory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on October 6, 2025. This means U.S. antitrust regulators did not move to block or extend review within that period. The transaction still depends on remaining customary closing conditions, required approvals and other regulatory clearances before the mergers can be completed.
Positive
- None.
Negative
- None.
Insights
HSR waiting period expiration removes a key U.S. antitrust hurdle for the DNOW–MRC Global merger, but the deal is not yet closed.
The filing explains that DNOW Inc. and MRC Global Inc. have a merger agreement involving a two-step structure, with MRC Global ultimately becoming a wholly owned subsidiary of DNOW. A significant condition was U.S. antitrust review under the Hart-Scott-Rodino Act, where deals cannot close until a waiting period expires or is terminated early.
The statutory waiting period under the HSR Act expired on October 6, 2025, indicating regulators did not extend the review within that window. This clears an important regulatory hurdle that can otherwise delay or block transactions. However, the companies state that the merger still depends on other required regulatory approvals and customary closing conditions, so completion timing and final terms remain tied to those remaining steps.
8-K Event Classification
FAQ
What did DNOW (DNOW) announce about its merger with MRC Global?
DNOW announced that the statutory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for its planned merger with MRC Global Inc. expired on October 6, 2025, marking a key U.S. antitrust milestone for the transaction.
Is the DNOW and MRC Global merger now fully approved?
No. The companies state that the merger and related transactions remain subject to other required regulatory approvals and customary closing conditions, even though the Hart-Scott-Rodino waiting period has expired.
How is the DNOW–MRC Global merger structured?
The agreement provides for a two-step merger: first, a DNOW subsidiary will merge with and into MRC Global, and then MRC Global will merge with another DNOW subsidiary, which will continue as a wholly owned subsidiary of DNOW Inc..
What does expiration of the HSR Act waiting period mean for DNOW?
Expiration of the Hart-Scott-Rodino waiting period means U.S. antitrust authorities did not take action to block or extend review within that period, allowing DNOW and MRC Global to move closer to closing, subject to remaining approvals and conditions.
Are there any other regulatory approvals needed for the DNOW–MRC Global deal?
Yes. DNOW notes that the merger is still conditioned on other required regulatory approvals and customary closing conditions beyond the Hart-Scott-Rodino waiting period.
